The COVID-19 and Cancer Consortium (CCC19) Registry
Study Title
The COVID-19 and Cancer Consortium (CCC19) Registry
Purpose
To collect granular information on cancer patients infected with COVID-19.
Eligibility
Suspected or lab-confirmed COVID-19
Current or past medical history of invasive malignancy
Study Process
Contact Principal Investigator for Information
Trial Details
Investigator:
IRB:
Willis-Knighton
IRB Number:
20.0004
Trial Type:
NA
Sponsor:
Vanderbilt University Medical Center
Contact Information:
Hematology Oncology Associates